nitazoxanide






73 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 11365729 Another failed promise? NTZ gets the nix. J Int Assoc Physicians AIDS Care 1998 Aug 1
2 14973242 Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci 2004 Feb 18 3
3 15771762 Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: a randomized-controlled trial. Aliment Pharmacol Ther 2005 Mar 15 2
4 16352460 Molecular survival strategies of Echinococcus multilocularis in the murine host. Parasitol Int 2006 1
5 16393357 14-3-3- and II/3-10-gene expression as molecular markers to address viability and growth activity of Echinococcus multilocularis metacestodes. Parasitology 2006 Jan 1
6 16540585 Development of the deep cerebellar nuclei: transcription factors and cell migration from the rhombic lip. J Neurosci 2006 Mar 15 3
7 17239134 Nitazoxanide or CD3+/CD4+ lymphocytes for recovery from severe Cryptosporidium infection after allogeneic bone marrow transplant? Pediatr Transplant 2007 Feb 1
8 19664635 The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation. Gastroenterology 2009 Nov 15
9 19944066 O-GlcNAcylation regulates hyperglycemia-induced GPX1 activation. Biochem Biophys Res Commun 2010 Jan 1 1
10 20547640 Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics 2010 Jul 1
11 20810563 Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice. Endocrinology 2010 Oct 5
12 21980765 A controlled study of nitazoxanide (NTZ) 3 years after treatment of hepatitis C genotype 4. J Egypt Soc Parasitol 2011 Aug 1
13 22430099 Nitazoxanide suppresses IL-6 production in LPS-stimulated mouse macrophages and TG-injected mice. Int Immunopharmacol 2012 May 7
14 22589723 Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis. PLoS Pathog 2012 6
15 22890894 Partial inhibition of aldose reductase by nitazoxanide and its molecular basis. ChemMedChem 2012 Nov 2
16 23553458 Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin. Arch Virol 2013 Sep 4
17 23825064 A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide. Mol Cancer Ther 2013 Sep 4
18 24202339 Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose? Cancers (Basel) 2013 Sep 10 1
19 24215285 Effect of nitazoxanide on erythrocytes. Basic Clin Pharmacol Toxicol 2014 May 1
20 24334180 Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. HIV Clin Trials 2013 Nov-Dec 1
21 24412397 Nitazoxanide: nematicidal mode of action and drug combination studies. Mol Biochem Parasitol 2014 Jan 1
22 24971706 Nitazoxanide, an antiviral thiazolide, depletes ATP-sensitive intracellular Ca(2+) stores. Virology 2014 Aug 6
23 25108173 Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antiviral Res 2014 Oct 1
24 25762088 Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study. Pharm Res 2015 Aug 3
25 25847384 A functional perspective of nitazoxanide as a potential anticancer drug. Mutat Res 2014 Oct 1
26 25911689 Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer. Mol Cancer Ther 2015 Jun 2
27 26974581 Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin. AIDS Res Hum Retroviruses 2016 Jul 4
28 27095301 Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus. J Infect Public Health 2016 May-Jun 1
29 28685770 Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction. Cell Res 2017 Aug 1
30 28748751 Update on Nitazoxanide: A Multifunctional Chemotherapeutic Agent. Curr Drug Discov Technol 2018 4
31 28798236 The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice. J Biol Chem 2017 Sep 22 1
32 29083417 Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer. Nat Chem Biol 2018 Jan 8
33 29244961 Time-dependent therapeutic roles of nitazoxanide on high-fat diet/streptozotocin-induced diabetes in rats: effects on hepatic peroxisome proliferator-activated receptor-gamma receptors. Can J Physiol Pharmacol 2018 May 2
34 29493458 Critical Insight into the Design of PPAR-γ Agonists by Virtual Screening Techniques. Curr Drug Discov Technol 2019 1
35 29722175 Lack of transformation zone in cervical Pap tests, should it be a concern? A quality assurance initiative. Diagn Cytopathol 2018 Jul 1
36 29992955 Nitazoxanide inhibits paramyxovirus replication by targeting the Fusion protein folding: role of glycoprotein-specific thiol oxidoreductase ERp57. Sci Rep 2018 Jul 11 1
37 30302016 Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma. Cell Death Dis 2018 Oct 9 4
38 30389778 Early diagnosis of progressive multifocal leucoencephalopathy: longitudinal lesion evolution. J Neurol Neurosurg Psychiatry 2019 Mar 1
39 30704979 Disruption of HBx-DDB1 by NTZ: New Mechanistic Insight Into an Old Drug With Broad Anti-infective Activities. Cell Mol Gastroenterol Hepatol 2019 1
40 30704981 Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx-DDB1 Interaction. Cell Mol Gastroenterol Hepatol 2019 6
41 30837866 Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways. Front Pharmacol 2019 2
42 30986380 Evaluation of nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis. Acta Trop 2019 Jul 2
43 31000769 Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice. Acta Pharmacol Sin 2019 Oct 14
44 31402258 The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus. iScience 2019 Sep 27 7
45 31776285 Astrovirus Replication Is Inhibited by Nitazoxanide <i>In Vitro</i> and <i>In Vivo</i>. J Virol 2020 Feb 14 2
46 32356241 Synthetic antiprotozoal thiazolide drug induced apoptosis in colorectal cancer cells: implications of IL-6/JAK2/STAT3 and p53/caspases-dependent signaling pathways based on molecular docking and in vitro study. Mol Cell Biochem 2020 Jun 17
47 32374827 A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle. Blood 2020 Aug 13 2
48 32392744 Nootkatone Inhibits Acute and Chronic Inflammatory Responses in Mice. Molecules 2020 May 7 1
49 32403005 Therapeutic potential of Nitazoxanide against Newcastle disease virus: A possible modulation of host cytokines. Cytokine 2020 Jul 1
50 32524281 Anti-infective nitazoxanide disrupts transcription of ribosome biogenesis-related genes in yeast. Genes Genomics 2020 Aug 3